Review



nc inhibitor  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress nc inhibitor
    Nc Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/HY-R00714/hsa-miR-34a-5p+mimic/pmc12440275-50-11-39
    Average 93 stars, based on 2 article reviews
    nc inhibitor - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Negative Control:

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma.
    Article Snippet: .. A synthetic negative control (Nc) mimic (sense: UUG UAc UAc AcA AAA GUA cUG; antisense: GUA cUU UUG UGU AGU AcA ANN), an Nc inhibitor (cAG UAc UUU UGU GUA GUA CAA; full‐length nucleotide with 2'‐methoxy modification), an hsa‐miR‐34a‐5p mimic (sense: UGG cAG UGU cUU AGc UGG UUG U; antisense: AAc cAG cUA AGA cAc UGc cAN N), and an hsa‐miR‐34a‐5p inhibitor (AcA Acc AGc UAA GAc AcU Gc; full‐length nucleotide with 2'‐methoxy modification) were purchased from MedchemExpress. .. Transfection was performed using a ViaFect Transfection Reagent (Promega corporation) following the manufacturer's instructions.

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma
    Article Snippet: Subsequently, the cells were incubated with a secondary antibody conjugated to Alexa Fluor 647 red fluorescent dye (1:50; cat. no. ab150079; Abcam) for another 1 h. Finally, Ki-67 + cells were visualized using a Nikon Ti2 fluorescence microscope (Nikon Corporation). .. A synthetic negative control (NC) mimic (sense: UUGUACUACACAAAAGUACUG; antisense: GUACUUUUGUGUAGUACAANN), an NC inhibitor (CAGUACUUUUGUGUAGUACAA; full-length nucleotide with 2′-methoxy modification), an hsa-miR-34a-5p mimic (sense: UGGCAGUGUCUUAGCUGGUUGU; antisense: AACCAGCUAAGACACUGCCANN), and an hsa-miR-34a-5p inhibitor (ACAACCAGCUAAGACACUGC; full-length nucleotide with 2′-methoxy modification) were purchased from MedChemExpress. .. Transfection was performed using a ViaFect Transfection Reagent (Promega Corporation) following the manufacturer's instructions.

    Modification:

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma.
    Article Snippet: .. A synthetic negative control (Nc) mimic (sense: UUG UAc UAc AcA AAA GUA cUG; antisense: GUA cUU UUG UGU AGU AcA ANN), an Nc inhibitor (cAG UAc UUU UGU GUA GUA CAA; full‐length nucleotide with 2'‐methoxy modification), an hsa‐miR‐34a‐5p mimic (sense: UGG cAG UGU cUU AGc UGG UUG U; antisense: AAc cAG cUA AGA cAc UGc cAN N), and an hsa‐miR‐34a‐5p inhibitor (AcA Acc AGc UAA GAc AcU Gc; full‐length nucleotide with 2'‐methoxy modification) were purchased from MedchemExpress. .. Transfection was performed using a ViaFect Transfection Reagent (Promega corporation) following the manufacturer's instructions.

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma
    Article Snippet: Subsequently, the cells were incubated with a secondary antibody conjugated to Alexa Fluor 647 red fluorescent dye (1:50; cat. no. ab150079; Abcam) for another 1 h. Finally, Ki-67 + cells were visualized using a Nikon Ti2 fluorescence microscope (Nikon Corporation). .. A synthetic negative control (NC) mimic (sense: UUGUACUACACAAAAGUACUG; antisense: GUACUUUUGUGUAGUACAANN), an NC inhibitor (CAGUACUUUUGUGUAGUACAA; full-length nucleotide with 2′-methoxy modification), an hsa-miR-34a-5p mimic (sense: UGGCAGUGUCUUAGCUGGUUGU; antisense: AACCAGCUAAGACACUGCCANN), and an hsa-miR-34a-5p inhibitor (ACAACCAGCUAAGACACUGC; full-length nucleotide with 2′-methoxy modification) were purchased from MedChemExpress. .. Transfection was performed using a ViaFect Transfection Reagent (Promega Corporation) following the manufacturer's instructions.



    Similar Products

    93
    MedChemExpress nc inhibitor
    Nc Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/HY-R00714/hsa-miR-34a-5p+mimic/pmc12440275-50-11-39
    Average 93 stars, based on 1 article reviews
    nc inhibitor - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress hsa mir 34a 5p mimic
    <t>Hsa-miR-34a</t> mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.
    Hsa Mir 34a 5p Mimic, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/HY-R00714/hsa-miR-34a-5p+mimic/pmc12440275-50-20-39
    Average 93 stars, based on 1 article reviews
    hsa mir 34a 5p mimic - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress hsa mir 34a 5p inhibitor
    <t>Hsa-miR-34a</t> mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.
    Hsa Mir 34a 5p Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/HY-R00714/hsa-miR-34a-5p+mimic/pmc12440275-50-28-39
    Average 93 stars, based on 1 article reviews
    hsa mir 34a 5p inhibitor - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Hsa-miR-34a mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.

    Journal: International Journal of Molecular Medicine

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma

    doi: 10.3892/ijmm.2025.5635

    Figure Lengend Snippet: Hsa-miR-34a mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.

    Article Snippet: A synthetic negative control (NC) mimic (sense: UUGUACUACACAAAAGUACUG; antisense: GUACUUUUGUGUAGUACAANN), an NC inhibitor (CAGUACUUUUGUGUAGUACAA; full-length nucleotide with 2′-methoxy modification), an hsa-miR-34a-5p mimic (sense: UGGCAGUGUCUUAGCUGGUUGU; antisense: AACCAGCUAAGACACUGCCANN), and an hsa-miR-34a-5p inhibitor (ACAACCAGCUAAGACACUGC; full-length nucleotide with 2′-methoxy modification) were purchased from MedChemExpress.

    Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Transfection, Control, Western Blot, Sequencing, Mutagenesis, Binding Assay, Plasmid Preparation, Luciferase, Cytotoxicity Assay

    Hsa-miR-34a mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.

    Journal: International Journal of Molecular Medicine

    Article Title: Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma

    doi: 10.3892/ijmm.2025.5635

    Figure Lengend Snippet: Hsa-miR-34a mediates the sesamin-induced downregulation of PD-L1 and enhances the cytotoxicity of NK cells. (A and B) The expression of hsa-miR-34a-5p in LUAD cells, treated with various concentrations of sesamin (0-100 μ M), was determined using a reverse transcription-quantitative PCR assay. (C and D) LUAD cells transfected with either a control inhibitor or hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M) for another 24 h. The protein levels of PD-L1 were detected using a western blot assay. (E) Schematic representation of the 3′-UTR of the WT PD-L1 sequence and the mutant PD-L1 sequence containing the miR-34a binding site. (F and G) LUAD cells were co-transfected with a PD-L1 plasmid (1 μ g/ μ l) and a miR-34a inhibitor (25 nM) for 24 h, followed by stimulation with sesamin for an additional 24 h. Relative luciferase and Renilla activities were then measured. (H) NK cytotoxicity assay revealing the immune evasion of CL1-5 cells transfected with a hsa-miR-34a-5p inhibitor (25 nM) for 24 h, followed by treatment with sesamin (100 μ M). (I and J) LUAD cells were transfected with either a control mimic or hsa-miR-34a-5p mimic (25 nM) for 24 h, and PD-L1 protein expression was measured using a western blot assay. (K) Immune evasion was assessed through a NK cytotoxicity assay after transfecting CL1-5 cells with a hsa-miR-34a-5p mimic (25 nM) for 24 h. Data are expressed as the mean ± SD for triplicate samples. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 relative to the control group.. PD-L1, programmed death ligand 1; NK cells; natural killer cells; miR, microRNA; LUAD, lung adenocarcinoma; UTR, untranslated region; WT, wild-type; ns, not significant.

    Article Snippet: A synthetic negative control (NC) mimic (sense: UUGUACUACACAAAAGUACUG; antisense: GUACUUUUGUGUAGUACAANN), an NC inhibitor (CAGUACUUUUGUGUAGUACAA; full-length nucleotide with 2′-methoxy modification), an hsa-miR-34a-5p mimic (sense: UGGCAGUGUCUUAGCUGGUUGU; antisense: AACCAGCUAAGACACUGCCANN), and an hsa-miR-34a-5p inhibitor (ACAACCAGCUAAGACACUGC; full-length nucleotide with 2′-methoxy modification) were purchased from MedChemExpress.

    Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Transfection, Control, Western Blot, Sequencing, Mutagenesis, Binding Assay, Plasmid Preparation, Luciferase, Cytotoxicity Assay